Glypican-3 targeted radiotherapy

N/A

Report date: 2023/04/10 14:29:12
NME

Base Information

Drug NameGlypican-3 targeted radiotherapy
Drug Alias NameGPC3 targeted radiotherapy
ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Synthetic peptide
Mechanisms of ActionIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRayzeBio IncPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesRayzeBio Inc
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A